Supportive Care for Breast Cancer Patients Taking Tamoxifen
October 14, 2013
30-50% of breast cancer patients stop taking their tamoxifen therapy early.
Breast cancer affects one in every eight American women. Join Dr. Nancy Peacock, Medical Oncologist specializing in breast cancer treatment (at Tennessee Oncology and Tri-Star Centennial Medical Center, Nashville) for an in-depth and frank discussion of the issues related to Oncology Supportive Care. Learn why certain long-term breast cancer therapy treatments are so vital to the ultimate success in managing the disease that affects women of all ages.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.